Spots Global Cancer Trial Database for folfox4
Every month we try and update this database with for folfox4 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Postoperative Folfox4 Only Versus Folfox4 Plus Transhepatic Arterial Chemotherapy (TAC) in the Treatment Unresectable Liver Metastasis of Colorectal Cancer | NCT00869271 | Unresectable Li... | tac + folfox4 Folfox4 | 18 Years - 75 Years | Fudan University | |
| Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum | NCT00580073 | Rectal Cancer | FOLFOX4 Cetuximab | 18 Years - | University of Wisconsin, Madison | |
| Preoperative Radiotherapy And ASTX660 in Rectum Cancer | NCT05912075 | Locally-advance... | mFOLFIRINOX Pelvic radiothe... Capecitabine TOLINAPANT (AST... Pelvic radiothe... FOLFOX4 CAPOX | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer (FDA IND 103675) | NCT01047475 | Colorectal Canc... | MB-6 Placebo | 20 Years - | Microbio Co Ltd | |
| Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma | NCT02527772 | Hepatocellular ... | Liposomal Doxor... FOLFOX4 | 18 Years - 75 Years | Guangxi Medical University | |
| A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC | NCT03092895 | Advanced Primar... Advanced Biliar... | SHR-1210 Apatinib FOLFOX4 GEMOX | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment. | NCT03605706 | Advanced Hepato... | SHR-1210 FOLFOX4 Placebo | 18 Years - | Jiangsu HengRui Medicine Co., Ltd. | |
| Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer | NCT00874406 | Colorectal Canc... | tac + folfox4 folfox4 | 18 Years - 75 Years | Fudan University | |
| Preoperative Radiotherapy And ASTX660 in Rectum Cancer | NCT05912075 | Locally-advance... | mFOLFIRINOX Pelvic radiothe... Capecitabine TOLINAPANT (AST... Pelvic radiothe... FOLFOX4 CAPOX | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment. | NCT03605706 | Advanced Hepato... | SHR-1210 FOLFOX4 Placebo | 18 Years - | Jiangsu HengRui Medicine Co., Ltd. | |
| HR Combined With FOLFOX4 for HCC With PVTT | NCT02452853 | Hepatocellular ... | HR FOLFOX4 | 18 Years - 75 Years | Sun Yat-sen University | |
| A Trial of Adjuvant Therapy After Hepatocarcinoma Resection Based on Folate Receptor-positive Circulating Tumor Cells | NCT04521491 | Hepatocellular ... | FOLFOX4(infusio... | 18 Years - 80 Years | Eastern Hepatobiliary Surgery Hospital | |
| Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum | NCT00580073 | Rectal Cancer | FOLFOX4 Cetuximab | 18 Years - | University of Wisconsin, Madison | |
| A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer | NCT02069041 | Carcinoma, Hepa... | Ramucirumab FOLFOX4 | 20 Years - 75 Years | Eli Lilly and Company | |
| Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer | NCT00202787 | Colorectal Canc... | FOLFOX-4+cetuxi... FOLFOX-4 | 18 Years - 75 Years | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | |
| A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer (FDA IND 103675) | NCT01047475 | Colorectal Canc... | MB-6 Placebo | 20 Years - | Microbio Co Ltd | |
| Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma | NCT02534337 | Hepatocellular ... | GEMOX FOLFOX4 | 18 Years - 75 Years | Guangxi Medical University | |
| Chemotherapy Combined With CIK Treating Colon Cancer | NCT03084809 | Colorectal Canc... Cytokine-induce... Postoperative C... Survival | Cytokine-induce... FOLFOX4 | 18 Years - 78 Years | China Meitan General Hospital | |
| Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer | NCT00874406 | Colorectal Canc... | tac + folfox4 folfox4 | 18 Years - 75 Years | Fudan University | |
| A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC | NCT03092895 | Advanced Primar... Advanced Biliar... | SHR-1210 Apatinib FOLFOX4 GEMOX | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer (FDA IND 103675) | NCT01047475 | Colorectal Canc... | MB-6 Placebo | 20 Years - | Microbio Co Ltd |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
